Email Updates

Search form

You are here

1 December 2017 VOLUME 18 ISSUE 48

Media Coverage

  • Despite being offered a daily pill to protect them from HIV, almost three-quarters of women sex workers had stopped taking the pills after a year. This is according to a study published in the PLoS journal last week, conducted by the TAPS Demonstration Study.

    December 1, 2017
    Health24
  • World AIDS Day, which takes place on Friday, was founded to raise awareness and remember those who lost their lives to the disease. But President Donald Trump’s statement on Thursday commemorating the day managed not to acknowledge one of the chief victims of the plague—the LGBTQ community—at all.

    December 1, 2017
    AP
  • Khoza is one of 524 young women using an HIV prevention pill as part of a demonstration project being conducted by the Centre for the Aids Programme of Research in South Africa (Caprisa) in Durban. The study began in March last year and will continue until the end of May 2018.

    December 1, 2017
    Bhekisisa
  • The New HIV Vaccine and Microbicide Advocacy Society had long advocated for the need to develop this roadmap to enhance various actors in the field to articulate plans in ways that will ensure measurable impact of the use of PrEP as part of the combination prevention package in Nigeria. Participants at the meeting agreed on the need for such a roadmap more so that PEPFAR was planning to roll out PrEP access to key populations this December 2017.

    December 1, 2017
    News Proof
  • Last year South Africa became the first country on the continent to register the use of a drug that could be used as an oral pre-exposure prophylaxis for HIV prevention....The PrEP rollout data shows that there is a relatively slow, but increasing, uptake of PrEP. There are concerns.

    December 1, 2017
    The Conversation
  • ViiV Healthcare, GlaxoSmithKline Plc’s HIV unit, said on Thursday it started an African study to evaluate long-acting injectable drug for the prevention of HIV infection in sexually active women. The HPTN 084 Phase III study will evaluate injections given every two months, ViiV Healthcare said.

    November 30, 2017
    Reuters
  • Researchers announced the launch of two big studies in Africa on Thursday to test a new HIV vaccine and a long-acting injectable drug, fueling hopes for better ways to protect against the virus that causes AIDS. The start of the three-year vaccine trial involving 2,600 women in southern Africa means that for the first time in more than a decade there are now two big HIV vaccine clinical trials taking place at the same time.

    November 30, 2017
    Reuters
  • A program that includes male circumcision and antiviral drug treatment led to a sharp drop in HIV infection rates in a high-risk region of Uganda, researchers report.

    November 30, 2017
    HealthDay
  • A short time ago, I was asked by a medical consultant if they needed to get a test after touching an HIV positive patient. I have seen nursing staff put two pairs of gloves on when dealing with patients. I have even witnessed administrative staff put on gloves just to handle the paper notes of those with HIV. Why do people continue to think and behave in this way?

    November 29, 2017
    General
    The Guardian
  • While people with HIV are living longer, they are also living with unique challenges regarding how to age well. New evidence suggests that there are indeed several simple but vital strategies that can help increase the likelihood of successful aging.

    November 29, 2017
    The Converstation
  • The number of patients receiving antiretroviral therapy from Joburg clinics has increased from 39,924 in 2011 to 296,485 in 2017, which represents an enormous 643% jump.

    November 29, 2017
    Polity
  • Ahead of World AIDS Day, the development advocacy group ONE Campaign has issued a sharp attack on the Trump administration’s proposed budget cuts and policy changes for US-funded HIV/AIDS programs around the world.

    November 29, 2017
    Devex
  • The number of people newly diagnosed with HIV in Europe reached its highest level in 2016 since records began, showing the region’s epidemic growing “at an alarming pace”, health officials said on Tuesday….Around 80 percent of those were in eastern Europe, the report found.

    November 28, 2017
    Reuters
  • According to the study from the Centers for Disease Control and Prevention, the estimated time it takes to get an HIV diagnosis from time of infection is now three years. This is a significant improvement from 2011, when the median time was three years and seven months.

    November 28, 2017
    CBS News
  • About 11 percent of medicines in developing countries are counterfeit and likely responsible for the deaths of tens of thousands of children from diseases like malaria and pneumonia every year, the World Health Organization said Tuesday.

    November 28, 2017
    General
    AP
  • In a letter sent to Sec. of State Rex Tillerson earlier this month, four senators from both parties expressed their "grave concerns about the impact" of the global gag rule, which bans humanitarian organizations around the world from receiving U.S. funds if they provide women with or even just refer women to abortion services.

    November 28, 2017
    Elle
  • The United Nations reports remarkable progress in containing HIV, the virus that causes AIDS. In its latest report, released in advance of World AIDS Day, UNAIDS said access to treatment has risen significantly. The report said 21 million HIV positive people are on treatment. That's more than half of all people living with HIV. The UN's goal is to end the pandemic by 2030.

    November 27, 2017
    VOA News
  • Medical authorities are publicly agreeing that people with undetectable viral loads cannot transmit the virus that causes AIDS. The policy change has profound implications for the way people view HIV. The change promises not just unprotected sex for couples…. but also reduced stigma for the 1.2 million Americans living with HIV.

    November 24, 2017
    Washington Post
  • About a dozen new types of microbicides are in the research pipeline, including some that could protect women against not only HIV infection but also other sexually transmitted infections and unwanted pregnancies. But this progress is in peril.

    November 23, 2017
    Bhekisisa

Published Research

Announcements